+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Pulmonary Hypertension Market and Competitive Landscape - 2020

  • ID: 5023467
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Pulmonary Hypertension Market and Competitive Landscape - 2020, provides comprehensive insights into the Pulmonary Hypertension pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Pulmonary Hypertension market size and drug sales. It also provides insights into Pulmonary Hypertension epidemiology and late stage pipeline.

This research covers the following: Pulmonary Hypertension treatment options, Pulmonary Hypertension late stage clinical trials pipeline, Pulmonary Hypertension prevalence by countries, Pulmonary Hypertension market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Pulmonary Hypertension pipeline: Find out drugs in clinical trials for the treatment of Pulmonary Hypertension by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Pulmonary Hypertension epidemiology: Find out the number of patients diagnosed (prevalence) with Pulmonary Hypertension by countries
  • Pulmonary Hypertension drugs: Identify key drugs marketed and prescribed for Pulmonary Hypertension in the US, including trade name, molecule name, and company
  • Pulmonary Hypertension drugs sales: Find out the sales value for Pulmonary Hypertension drugs by countries
  • Pulmonary Hypertension market valuations: Find out the market size for Pulmonary Hypertension drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Pulmonary Hypertension drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Pulmonary Hypertension drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Pulmonary Hypertension market
  • Develop in-depth knowledge of competition and markets
  • Analyze Pulmonary Hypertension drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Pulmonary Hypertension market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Pulmonary Hypertension Treatment Options

2. Pulmonary Hypertension Pipeline Insights
2.1. Pulmonary Hypertension Phase 3 Clinical Trials
2.2. Pulmonary Hypertension Phase 2 Clinical Trials
2.3. Pulmonary Hypertension Phase 1 Clinical Trials

3. Pulmonary Hypertension Epidemiology Analysis by Countries

4. Germany Pulmonary Hypertension Market Insights
4.1. Marketed Drugs for Pulmonary Hypertension in Germany
4.2. Germany Pulmonary Hypertension Market Size & Forecast
4.3. Germany Pulmonary Hypertension Drugs Sales Forecast
4.4. Germany Pulmonary Hypertension Market Share Analysis

5. France Pulmonary Hypertension Market Insights
5.1. Marketed Drugs for Pulmonary Hypertension in France
5.2. France Pulmonary Hypertension Market Size & Forecast
5.3. France Pulmonary Hypertension Product Sales Forecast
5.4. France Pulmonary Hypertension Market Share Analysis

6. Italy Pulmonary Hypertension Market Insights
6.1. Marketed Drugs for Pulmonary Hypertension in Italy
6.2. Italy Pulmonary Hypertension Market Size & Forecast
6.3. Italy Pulmonary Hypertension Product Sales Forecast
6.4. Italy Pulmonary Hypertension Market Share Analysis

7. Spain Pulmonary Hypertension Market Insights
7.1. Marketed Drugs for Pulmonary Hypertension in Spain
7.2. Spain Pulmonary Hypertension Market Size & Forecast
7.3. Spain Pulmonary Hypertension Product Sales Forecast
7.4. Spain Pulmonary Hypertension Market Share Analysis

8. UK Pulmonary Hypertension Market Insights
8.1. Marketed Drugs for Pulmonary Hypertension in UK
8.2. UK Pulmonary Hypertension Market Size & Forecast
8.3. UK Pulmonary Hypertension Product Sales Forecast
8.4. UK Pulmonary Hypertension Market Share Analysis

9. Europe Pulmonary Hypertension Market Insights
9.1. Europe Pulmonary Hypertension Market Size & Forecast
9.2. Europe Pulmonary Hypertension Product Sales Forecast
9.3. Europe Pulmonary Hypertension Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Pulmonary Hypertension Phase 3 Clinical Trials, Global, 2020
Table 2: Pulmonary Hypertension Phase 2 Clinical Trials, Global, 2020
Table 3: Pulmonary Hypertension Phase 1 Clinical Trials, Global, 2020
Table 4: Pulmonary Hypertension Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Pulmonary Hypertension in Germany, 2019
Table 6: Germany Pulmonary Hypertension Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Pulmonary Hypertension Product Sales ($mn), 2016 - 2024
Table 8: Germany Pulmonary Hypertension Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Pulmonary Hypertension in France, 2019
Table 10: France Pulmonary Hypertension Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Pulmonary Hypertension Product Sales ($mn), 2016 - 2024
Table 12: France Pulmonary Hypertension Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Pulmonary Hypertension in Italy, 2019
Table 14: Italy Pulmonary Hypertension Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Pulmonary Hypertension Product Sales ($mn), 2016 - 2024
Table 16: Italy Pulmonary Hypertension Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Pulmonary Hypertension in Spain, 2019
Table 18: Spain Pulmonary Hypertension Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Pulmonary Hypertension Product Sales ($mn), 2016 - 2024
Table 20: Spain Pulmonary Hypertension Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Pulmonary Hypertension in UK, 2019
Table 22: UK Pulmonary Hypertension Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Pulmonary Hypertension Product Sales ($mn), 2016 - 2024
Table 24: UK Pulmonary Hypertension Market Events and Trends, 2016 - 2024
Table 25: Europe Pulmonary Hypertension Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Pulmonary Hypertension Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Pulmonary Hypertension Pipeline by Phase (%), Global, 2020
Figure 2: Pulmonary Hypertension Prevalence by Countries, 2016 - 2024
Figure 3: Germany Pulmonary Hypertension Market Size ($mn), 2016 - 2024
Figure 4: Germany Pulmonary Hypertension Product Sales ($mn), 2016 - 2024
Figure 5: Germany Pulmonary Hypertension Market Share by Drugs (%), 2019
Figure 6: Germany Pulmonary Hypertension Market - Future Market Share (%), 2024
Figure 7: France Pulmonary Hypertension Market Size ($mn), 2016 - 2024
Figure 8: France Pulmonary Hypertension Product Sales ($mn), 2016 - 2024
Figure 9: France Pulmonary Hypertension Market Share by Drugs (%), 2019
Figure 10: France Pulmonary Hypertension Market - Future Market Share (%), 2024
Figure 11: Italy Pulmonary Hypertension Market Size ($mn), 2016 - 2024
Figure 12: Italy Pulmonary Hypertension Product Sales ($mn), 2016 - 2024
Figure 13: Italy Pulmonary Hypertension Market Share by Drugs (%), 2019
Figure 14: Italy Pulmonary Hypertension Market - Future Market Share (%), 2024
Figure 15: Spain Pulmonary Hypertension Market Size ($mn), 2016 - 2024
Figure 16: Spain Pulmonary Hypertension Product Sales ($mn), 2016 - 2024
Figure 17: Spain Pulmonary Hypertension Market Share by Drugs (%), 2019
Figure 18: Spain Pulmonary Hypertension Market - Future Market Share (%), 2024
Figure 19: UK Pulmonary Hypertension Market Size ($mn), 2016 - 2024
Figure 20: UK Pulmonary Hypertension Product Sales ($mn), 2016 - 2024
Figure 21: UK Pulmonary Hypertension Market Share by Drugs (%), 2019
Figure 22: UK Pulmonary Hypertension Market - Future Market Share (%), 2024
Figure 23: Europe Pulmonary Hypertension Market Size ($mn), 2016 - 2024
Figure 24: Europe Pulmonary Hypertension Product Sales ($mn), 2016 - 2024
Figure 25: Europe Pulmonary Hypertension Market Share by Drugs (%), 2019
Figure 26: Europe Pulmonary Hypertension Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll